IDH2 and acute myeloid leukemia: Mutations in some genes, particularly those associated with epigenetic modification such as DNMT3A and IDH2, are acquired early in leukaemic development are therefore present in nearly all clonal progeny and are almost always retained in AML at relapse 91, 92.